BioNexus Gene Lab (BGLC) Capital Expenditures Growth (1y) (2019 - 2026)
BioNexus Gene Lab (BGLC) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 5.67% |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | -26.94% |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | -7.67% |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | - |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | -17.46% |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | -44.31% |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | - |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 67.24% |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | -16.39% |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | -96.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.41% |
| Dec 31, 2025 | -75.71% |
| Sep 30, 2025 | -97.25% |
| Jun 30, 2025 | 1,070.70% |
| Mar 31, 2025 | -58.75% |
| Dec 31, 2024 | 329.24% |
| Sep 30, 2024 | 86.38% |
| Jun 30, 2024 | -93.44% |
| Mar 31, 2024 | 60.82% |
| Dec 31, 2023 | -99.82% |
| Sep 30, 2023 | 419.18% |
| Jun 30, 2023 | 2,060.94% |
| Mar 31, 2023 | -57.61% |
| Dec 31, 2022 | 39,908.29% |
| Sep 30, 2022 | -8,266.83% |
| Jun 30, 2022 | 94.14% |
| Mar 31, 2022 | 3,888.97% |
| Dec 31, 2021 | -99.70% |
| Jun 30, 2021 | 33,400.00% |
| Mar 31, 2021 | 162.87% |